The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting

Zhenwang Zhang1, Huitong Bu1, Jingwei Yu1

  • 1State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, Changsha, Hunan 410082, China.

Theranostics
|June 28, 2019
PubMed

Insights

A novel compound, M1-138, effectively inhibits cancer cell proliferation and migration by targeting transcription factor FOXM1 and its interaction with SMAD3. This therapeutic strategy shows promise for developing new anti-cancer drugs.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Development

Background:

  • Transcription factor FOXM1 is crucial for cell proliferation, DNA repair, and cancer metastasis.
  • Inhibiting FOXM1 can prevent cancer initiation and progression, making it a key therapeutic target.
  • The N-terminus of FOXM1 regulates its transcriptional activity and interaction with SMAD3.

Purpose of the Study:

  • To investigate the anti-cancer effects of a novel recombinant FOXM1 N-terminal domain (1-138aa) fused with a cell-penetrating peptide, named M1-138.
  • To analyze the impact of M1-138 on cancer cell proliferation, migration, and tumorigenicity.
  • To elucidate the molecular mechanisms underlying M1-138's anti-cancer activity.

Main Methods:

  • Production of M1-138 using an E. coli expression system.
  • In vitro analysis of cancer cell proliferation, migration, and colony formation.
  • Assays to evaluate DNA binding, transcriptional activity, protein interactions, and mRNA/protein levels.
  • In vivo studies using nude mouse xenograft models.

Main Results:

  • M1-138 significantly reduced cancer cell proliferation and migration.
  • The compound attenuated FOXM1 transcriptional activity by interfering with FOXM1 and SMAD3 interaction.
  • M1-138 inhibited tumor growth in vivo without observable toxicity.

Conclusions:

  • M1-138 demonstrates potent anti-cancer properties by targeting FOXM1 and SMAD3.
  • The compound effectively inhibits cancer cell proliferation, migration, and tumorigenicity.
  • M1-138 represents a promising drug candidate for developing novel anti-cancer therapeutics.

Related Concept Videos

Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.9K
Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.7K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.2K
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K